A systematic review on the efficacy of tranexamic acid in head and neck surgery
Clinical Otolaryngology · 2023
DOI: 10.1111/coa.14059 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Otolaryngology, 2023. Verfasst von Warda Jamshaid und 5 weiteren Autor:innen. Beteiligte Einrichtung: Birmingham Medical School, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents, Tonsillectomy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Intraoperative and postoperative blood loss is a major risk in head and neck (H&N) surgery. Recently the use of tranexamic acid (TXA) has been investigated by multiple studies for reducing intraoperative and postoperative bleeding, however reported results are variable.
Objectives
To determine the safety and efficacy of TXA use in H&N surgery.
Methods
Systematic review of MEDLINE, EMBASE, CINAHL, Cochrane Library, PubMed, ClinicalKey, and Clinicaltrials.gov according to the PRISMA guidelines. Studies were included if they reported on intraoperative bleeding, volume or duration of postoperative drain or return to theatre rate for postoperative haemorrhage in adult populations following use of TXA. Risk of bias assessment with Cochrane Risk of Bias (RoB2) tool for randomised controlled trials and Newcastle–Ottawa Scale tool for non‐randomised studies.
Results
Sixteen studies were identified (114 407 patients). Eight studies evaluated TXA in major H&N surgery and eight studies in tonsillectomy. Primary outcomes were reduction in intraoperative or postoperative bleeding. Secondary outcomes included the duration of postoperative drain placement and return to theatre rate. No adverse events were reported in any patients. TXA is effective in reducing intraoperative blood loss in tonsillectomy. However, the effect on posttonsillectomy haemorrhage was unclear. Insufficient evidence exists of benefit of TXA on intraoperative bleeding in major H&N procedures. Postoperative drainage volumes were significantly reduced in most major H&N studies. The duration of drain placement and risk of blood transfusion was unchanged in most cases.
Conclusion
TXA use is safe in H&N patients. Whilst sufficient evidence exists to support the use of TXA in tonsillectomy, insufficient evidence exists to recommend use in major H&N surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Birmingham Medical School, University of Birmingham, Birmingham, UK.
- Cardiff University, Cardiff, UK.
- Department of Ear, Nose and Throat Surgery, University Hospitals Birmingham NHS Foundation, UK.
- Institute of Head and Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, UK.
- Department of Clinical Neurosciences, University of Cambridge Trust, Cambridge, UK.
- Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
ORCID-Profile: Warda Jamshaid, Maryam Jamshaid, Chris Coulson, Neil Sharma, Jameel Muzaffar, Hannah Nieto
Zitieren
APA
Jamshaid, W., Jamshaid, M., Coulson, C., Sharma, N., Muzaffar, J., & Nieto, H. (2023). A systematic review on the efficacy of tranexamic acid in head and neck surgery. Clinical Otolaryngology. https://doi.org/10.1111/coa.14059
Vancouver
Jamshaid W, Jamshaid M, Coulson C, Sharma N, Muzaffar J, Nieto H. A systematic review on the efficacy of tranexamic acid in head and neck surgery. Clinical Otolaryngology. 2023. doi:10.1111/coa.14059
BibTeX
@article{Jamshaid2023,
author = {Jamshaid, Warda and Jamshaid, Maryam and Coulson, Chris and Sharma, Neil and Muzaffar, Jameel and Nieto, Hannah},
title = {A systematic review on the efficacy of tranexamic acid in head and neck surgery},
journal = {Clinical Otolaryngology},
year = {2023},
doi = {10.1111/coa.14059}
}
EUVIMED